{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006954",
      "entity_text" : "inflammatory response",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "be:HES",
      "entity_text" : "HES",
      "entity_type" : "family"
    },
    "hypothesis_information" : true
  },
  "verbose_text" : "We hypothesized that 6% HES 130/0.4 as CPB priming solution would attenuate the systemic inflammatory response with a reduction of pro inflammatory cytokine levels, providing protective effects against organ tissue damage during CPB [XREF_BIBR].",
  "reading_complete" : "2020-08-08T19:35:40Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-08T19:31:37Z",
  "trigger" : "attenuate",
  "evidence" : [ "HES 130/0.4 as CPB priming solution would attenuate the systemic inflammatory response" ],
  "pmc_id" : "7236599",
  "score" : 0
}